High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML

被引:63
|
作者
Zhao, Yue [1 ]
Liu, Qi [2 ,3 ]
Acharya, Pankaj [1 ]
Stengel, Kristy R. [1 ]
Sheng, Quanhu [2 ]
Zhou, Xiaofan [4 ]
Kwak, Hojoong [5 ]
Fischer, Melissa A. [6 ]
Bradner, James E. [7 ]
Strickland, Stephen A. [6 ,8 ]
Mohan, Sanjay R. [6 ,8 ]
Savona, Michael R. [6 ,8 ]
Venters, Bryan J. [9 ]
Zhou, Ming-Ming [10 ]
Lis, John T. [5 ]
Hiebert, Scott W. [1 ,8 ]
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Quantitat Sci, Sch Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA
[5] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA
[6] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA
[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[8] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[9] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[10] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA
来源
CELL REPORTS | 2016年 / 16卷 / 07期
关键词
ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION ELONGATION-FACTOR; II-DEPENDENT TRANSCRIPTION; BROMODOMAIN PROTEIN BRD4; P-TEFB; C-KIT; CELL-LINES; MUTATIONS; CANCER; INITIATION;
D O I
10.1016/j.celrep.2016.07.032
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bromodomain and extra-terminal domain (BET) family inhibitors offer an approach to treating hematological malignancies. We used precision nuclear run-on transcription sequencing (PRO-seq) to create high-resolution maps of active RNA polymerases across the genome in t(8;21) acute myeloid leukemia (AML), as these polymerases are exceptionally sensitive to BET inhibitors. PRO-seq identified over 1,400 genes showing impaired release of promoter-proximal paused RNA polymerases, including the stem cell factor receptor tyrosine kinase KIT that is mutated in t(8; 21) AML. PRO-seq also identified an enhancer 30 to KIT. Chromosome conformation capture confirmed contacts between this enhancer and the KIT promoter, while CRISPRi-mediated repression of this enhancer impaired cell growth. PROseq also identified microRNAs, including MIR29C and MIR29B2, that target the anti-apoptotic factor MCL1 and were repressed by BET inhibitors. MCL1 protein was upregulated, and inhibition of BET proteins sensitized t(8:21)-containing cells to MCL1 inhibition, suggesting a potential mechanism of resistance to BET-inhibitor-induced cell death.
引用
收藏
页码:2003 / 2016
页数:14
相关论文
empty
未找到相关数据